<?xml version='1.0' encoding='UTF-8'?>
<uniprot>
<entry dataset="TrEMBL" created="2001-06-01" modified="2015-01-07" version="63">
<accession>Q9BJJ9</accession>
<name>Q9BJJ9_PLAFA</name>
<protein>
<submittedName>
<fullName evidence="15">Enoyl-ACP reductase</fullName>
</submittedName>
</protein>
<gene>
<name type="primary" evidence="15">FabI</name>
</gene>
<organism evidence="15">
<name type="scientific">Plasmodium falciparum</name>
<dbReference type="NCBI Taxonomy" id="5833"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Alveolata</taxon>
<taxon>Apicomplexa</taxon>
<taxon>Aconoidasida</taxon>
<taxon>Haemosporida</taxon>
<taxon>Plasmodium</taxon>
<taxon>Plasmodium (Laverania)</taxon>
</lineage>
</organism>
<reference key="1" evidence="15">
<citation type="journal article" date="2001" name="Nat. Med." volume="7" first="167" last="173">
<title>Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum.</title>
<authorList>
<person name="Surolia N."/>
<person name="Surolia A."/>
</authorList>
<dbReference type="PubMed" id="11175846"/>
<dbReference type="DOI" id="10.1038/84612"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE</scope>
</reference>
<reference key="2" evidence="1 2">
<citation type="journal article" date="2004" name="J. Mol. Biol." volume="343" first="147" last="155">
<title>Structural basis for the variation in triclosan affinity to enoyl reductases.</title>
<authorList>
<person name="Pidugu L.S."/>
<person name="Kapoor M."/>
<person name="Surolia N."/>
<person name="Surolia A."/>
<person name="Suguna K."/>
</authorList>
<dbReference type="PubMed" id="15381426"/>
<dbReference type="DOI" id="10.1016/j.jmb.2004.08.033"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF 96-424 IN COMPLEX WITH NAD</scope>
</reference>
<reference key="3" evidence="3 4 5">
<citation type="journal article" date="2005" name="Bioorg. Med. Chem. Lett." volume="15" first="5247" last="5252">
<title>Synthesis, biological activity, and X-ray crystal structural analysis of diaryl ether inhibitors of malarial enoyl acyl carrier protein reductase. Part 1: 4'-substituted triclosan derivatives.</title>
<authorList>
<person name="Freundlich J.S."/>
<person name="Anderson J.W."/>
<person name="Sarantakis D."/>
<person name="Shieh H.M."/>
<person name="Yu M."/>
<person name="Valderramos J.C."/>
<person name="Lucumi E."/>
<person name="Kuo M."/>
<person name="Jacobs W.R."/>
<person name="Fidock D.A."/>
<person name="Schiehser G.A."/>
<person name="Jacobus D.P."/>
<person name="Sacchettini J.C."/>
</authorList>
<dbReference type="PubMed" id="16198563"/>
<dbReference type="DOI" id="10.1016/j.bmcl.2005.08.044"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.68 ANGSTROMS) OF 97-432 IN COMPLEX WITH NAD</scope>
</reference>
<reference key="4" evidence="6 7 8">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="25436" last="25444">
<title>X-ray structural analysis of Plasmodium falciparum enoyl acyl carrier protein reductase as a pathway toward the optimization of triclosan antimalarial efficacy.</title>
<authorList>
<person name="Freundlich J.S."/>
<person name="Wang F."/>
<person name="Tsai H.C."/>
<person name="Kuo M."/>
<person name="Shieh H.M."/>
<person name="Anderson J.W."/>
<person name="Nkrumah L.J."/>
<person name="Valderramos J.C."/>
<person name="Yu M."/>
<person name="Kumar T.R."/>
<person name="Valderramos S.G."/>
<person name="Jacobs W.R."/>
<person name="Schiehser G.A."/>
<person name="Jacobus D.P."/>
<person name="Fidock D.A."/>
<person name="Sacchettini J.C."/>
</authorList>
<dbReference type="PubMed" id="17567585"/>
<dbReference type="DOI" id="10.1074/jbc.M701813200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF 96-425 IN COMPLEX WITH NAD</scope>
</reference>
<reference key="5" evidence="12 13 14">
<citation type="journal article" date="2010" name="IUBMB Life" volume="62" first="467" last="476">
<title>X-ray crystallographic analysis of the complexes of enoyl acyl carrier protein reductase of Plasmodium falciparum with triclosan variants to elucidate the importance of different functional groups in enzyme inhibition.</title>
<authorList>
<person name="Maity K."/>
<person name="Bhargav S.P."/>
<person name="Sankaran B."/>
<person name="Surolia N."/>
<person name="Surolia A."/>
<person name="Suguna K."/>
</authorList>
<dbReference type="PubMed" id="20503440"/>
<dbReference type="DOI" id="10.1002/iub.327"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.96 ANGSTROMS) OF 96-424 IN COMPLEX WITH NAD</scope>
</reference>
<reference key="6" evidence="9 10 11">
<citation type="journal article" date="2011" name="IUBMB Life" volume="63" first="30" last="41">
<title>Effect of substrate binding loop mutations on the structure, kinetics, and inhibition of enoyl acyl carrier protein reductase from Plasmodium falciparum.</title>
<authorList>
<person name="Maity K."/>
<person name="Banerjee T."/>
<person name="Prabakaran N."/>
<person name="Surolia N."/>
<person name="Surolia A."/>
<person name="Suguna K."/>
</authorList>
<dbReference type="PubMed" id="21280175"/>
<dbReference type="DOI" id="10.1002/iub.412"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.05 ANGSTROMS) OF 96-424 IN COMPLEX WITH NAD</scope>
</reference>
<dbReference type="EMBL" id="AF332609">
<property type="protein sequence ID" value="AAK38274.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="PDB" id="1UH5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A/B=96-424"/>
</dbReference>
<dbReference type="PDB" id="1V35">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B=96-424"/>
</dbReference>
<dbReference type="PDB" id="1ZSN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.99"/>
<property type="chains" value="A/B=97-432"/>
</dbReference>
<dbReference type="PDB" id="1ZXB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.68"/>
<property type="chains" value="A/B=97-432"/>
</dbReference>
<dbReference type="PDB" id="1ZXL">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A/B=97-432"/>
</dbReference>
<dbReference type="PDB" id="2NQ8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B=97-325"/>
</dbReference>
<dbReference type="PDB" id="2OL4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.26"/>
<property type="chains" value="A/B=96-425"/>
</dbReference>
<dbReference type="PDB" id="2OOS">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A/B=96-425"/>
</dbReference>
<dbReference type="PDB" id="3AM3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B=96-424"/>
</dbReference>
<dbReference type="PDB" id="3AM4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B=96-424"/>
</dbReference>
<dbReference type="PDB" id="3AM5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.05"/>
<property type="chains" value="A/B=96-424"/>
</dbReference>
<dbReference type="PDB" id="3LSY">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.85"/>
<property type="chains" value="A/B=96-424"/>
</dbReference>
<dbReference type="PDB" id="3LT0">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.96"/>
<property type="chains" value="A/B=96-424"/>
</dbReference>
<dbReference type="PDB" id="3LT1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A/B=96-424"/>
</dbReference>
<dbReference type="PDB" id="3LT2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B=96-424"/>
</dbReference>
<dbReference type="PDB" id="3LT4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.25"/>
<property type="chains" value="A/B=96-424"/>
</dbReference>
<dbReference type="PDBsum" id="1UH5"/>
<dbReference type="PDBsum" id="1V35"/>
<dbReference type="PDBsum" id="1ZSN"/>
<dbReference type="PDBsum" id="1ZXB"/>
<dbReference type="PDBsum" id="1ZXL"/>
<dbReference type="PDBsum" id="2NQ8"/>
<dbReference type="PDBsum" id="2OL4"/>
<dbReference type="PDBsum" id="2OOS"/>
<dbReference type="PDBsum" id="3AM3"/>
<dbReference type="PDBsum" id="3AM4"/>
<dbReference type="PDBsum" id="3AM5"/>
<dbReference type="PDBsum" id="3LSY"/>
<dbReference type="PDBsum" id="3LT0"/>
<dbReference type="PDBsum" id="3LT1"/>
<dbReference type="PDBsum" id="3LT2"/>
<dbReference type="PDBsum" id="3LT4"/>
<dbReference type="ProteinModelPortal" id="Q9BJJ9"/>
<dbReference type="IntAct" id="Q9BJJ9">
<property type="interactions" value="1"/>
</dbReference>
<dbReference type="BindingDB" id="Q9BJJ9"/>
<dbReference type="ChEMBL" id="CHEMBL1275211"/>
<dbReference type="EvolutionaryTrace" id="Q9BJJ9"/>
<dbReference type="GO" id="GO:0000166">
<property type="term" value="F:nucleotide binding"/>
<property type="evidence" value="IEA:UniProtKB-KW"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.720">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR016040">
<property type="entry name" value="NAD(P)-bd_dom"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002" evidence="1 2">3D-structure</keyword>
<keyword id="KW-0520" evidence="1 2">NAD</keyword>
<keyword id="KW-0547" evidence="1 2">Nucleotide-binding</keyword>
<feature type="nucleotide phosphate-binding region" description="NAD" evidence="1 2 3">
<location>
<begin position="105"/>
<end position="106"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="NAD" evidence="1 2 3">
<location>
<begin position="168"/>
<end position="170"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="NAD" evidence="1 2 3">
<location>
<begin position="216"/>
<end position="218"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="NAD" evidence="1 2 3">
<location>
<begin position="315"/>
<end position="319"/>
</location>
</feature>
<feature type="binding site" description="NAD; via amide nitrogen" evidence="1 2 3">
<location>
<position position="111"/>
</location>
</feature>
<feature type="binding site" description="NAD" evidence="1 2 3">
<location>
<position position="131"/>
</location>
</feature>
<feature type="binding site" description="NAD; via carbonyl oxygen" evidence="3">
<location>
<position position="265"/>
</location>
</feature>
<feature type="binding site" description="NAD" evidence="1 2 3">
<location>
<position position="285"/>
</location>
</feature>
<feature type="non-terminal residue" evidence="15">
<location>
<position position="432"/>
</location>
</feature>
<evidence key="1" type="ECO:0000213">
<source>
<dbReference type="PDB" id="1UH5"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000213">
<source>
<dbReference type="PDB" id="1V35"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000213">
<source>
<dbReference type="PDB" id="1ZSN"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000213">
<source>
<dbReference type="PDB" id="1ZXB"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000213">
<source>
<dbReference type="PDB" id="1ZXL"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000213">
<source>
<dbReference type="PDB" id="2NQ8"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000213">
<source>
<dbReference type="PDB" id="2OL4"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000213">
<source>
<dbReference type="PDB" id="2OOS"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000213">
<source>
<dbReference type="PDB" id="3AM3"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000213">
<source>
<dbReference type="PDB" id="3AM4"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000213">
<source>
<dbReference type="PDB" id="3AM5"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000213">
<source>
<dbReference type="PDB" id="3LSY"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000213">
<source>
<dbReference type="PDB" id="3LT0"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000213">
<source>
<dbReference type="PDB" id="3LT1"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000313">
<source>
<dbReference type="EMBL" id="AAK38274.1"/>
</source>
</evidence>
<sequence length="432" mass="49827" checksum="8B3241DB53ACF65F" modified="2001-06-01" version="1" fragment="single">
MNKISQRLLFLFLHFYTTVCFIQNNTQKTFHNVLQNEQIRGKEKAFYRKEKRENIFIGNK
MKHVHNMNNTHNNNHYMEKEEQDASNINKIKEENKNEDICFIAGIGDTNGYGWGIAKELS
KRNVKIIFGIWPPVYNIFMKNYKNGKFDNDMIIDKDKKMNILDMLPFDASFDTANDIDEE
TKNNKRYNMLQNYTIEDVANLIHQKYGKINMLVHSLANAKEVQKDLLNTSRKGYLDALSK
SSYSLISLCKYFVNIMKPQSSIISLTYHASQKVVPGYGGGMSSAKAALESDTRVLAYHLG
RNYNIRINTISAGPLKSRAATAINKLNNTYENNTNQNKNRNRHDVHNIMNNSGEKEEKKI
SASQNYTFIDYAIEYSEKYAPLRQKLLSTDIGSVASFLLSRESRAITGQTIYVDNGLNIM
FLPDDIYRNENE
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>